Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Relmada Therapeutics Inc
(NQ:
RLMD
)
3.610
+0.120 (+3.44%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Relmada Therapeutics Inc
< Previous
1
2
3
4
Next >
121 Stocks That Hit Their 52-Week Low
October 14, 2022
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.
Via
Benzinga
Relmada Stock Tumbles To 52-Week Low On Failed Depression Trial
October 13, 2022
Via
Benzinga
Earnings Scheduled For August 11, 2022
August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022
October 14, 2022
Upgrades
Via
Benzinga
Dow Surges 950 Points; S&P 500 Rises 3%
October 13, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones jumping around 950 points on Thursday.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 13, 2022
Gainers
Via
Benzinga
Why Otonomy Shares Dipped By Around 54%; Here Are 67 Biggest Movers From Yesterday
October 14, 2022
Gainers Nutex Health Inc. (NASDAQ: NUTX) jumped 72.4% to settle at $0.9551 on Thursday. Nutex Health recently provided a corporate update.
Via
Benzinga
Stocks Stage Midday Comeback After Red-Hot CPI Data
October 13, 2022
The market is brushing off this morning's CPI data.
Via
Talk Markets
Why Is Axsome Therapeutics (AXSM) Stock Up Today?
October 13, 2022
Sometimes, company shares can catch a bid when a rival gets bad news. That's happening with Axsome today as AXSM stock moves higher.
Via
InvestorPlace
Why Laser Photonics Shares Are Trading Higher By Around 44%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
October 13, 2022
Gainers FedNat Holding Company (NASDAQ: FNHC) shares jumped 89% to $0.4242 after dipping 34% on Wednesday.
Via
Benzinga
Gold Down 1.5%; Domino's Pizza Shares Spike Higher
October 13, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 150 points on Thursday.
Via
Benzinga
Why Are Tech Stocks Down Today?
October 13, 2022
Tech stocks aren't doing so hot on Thursday as investors react to the latest data from the Consumer Price Index (CPI) report for September.
Via
InvestorPlace
Progressive, Asana And Some Other Big Stocks Moving Lower On Thursday
October 13, 2022
U.S. stocks traded lower, with the Dow Jones gaining more than 100 points on Thursday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Is Relmada (RLMD) Stock Down 78% Today?
October 13, 2022
Relmada Therapeutics (RLMD) stock is plummeting on Thursday as investors react to results from a Phase 3 clinical trial.
Via
InvestorPlace
Relmada Tanks After 'Paradoxical Results' Undermine Depression Drug; Axsome Surges
October 13, 2022
The company noted "paradoxical results" where the placebo, at times, topped the drug.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 13, 2022
Gainers Corbus Pharmaceuticals (NASDAQ:CRBP) shares rose 24.6% to $0.14 during Thursday's pre-market session. The market value of their outstanding shares is at $17.1 million.
Via
Benzinga
Why Relmada Therapeutics Shares Are Trading Lower By 84%; Here Are 23 Stocks Moving Premarket
October 13, 2022
Gainers Laser Photonics Corporation (NASDAQ: LASE) shares rose 45% to $4.24 in pre-market trading. Laser Photonics announced that Coca-Cola recently completed the implementation of its first CleanTech...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 20, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Covid Exposed A 'Brain Health Pandemic' — Here's How Biotech Stocks Like Biogen, Sage Therapeutics Could Help
August 11, 2022
Today's depression drugs don't fit many patients' needs. Biotech companies may change that.
Via
Investor's Business Daily
Recap of Tuesday's Biotech Catalysts - End Of the Day Summary
August 09, 2022
Via
Benzinga
Relmada Secures FDA Fast Track Status For Depressive Disorder Candidate
August 09, 2022
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Relmada Therapeutics’ (NASDAQ: RLMD) lead asset REL-1017 as a monotherapy for the treatment major depressive disorder...
Via
Benzinga
Global Central Nervous System Treatment Market Is Expected to Reach $166 Billion In 2028
May 26, 2022
Palm Beach, FL – May 26, 2022 – FinancialNewsMedia.com News Commentary – Worldwide, there is a rapid increase in the prevalence and incidence of neurological disorders such as multiple sclerosis,...
Via
FinancialNewsMedia
Exposures
COVID-19
10 Biggest Price Target Changes For Monday
May 09, 2022
Morgan Stanley cut Guardant Health, Inc. (NASDAQ: GH) price target from $120 to $85. Guardant Health shares rose 4.3% to $40.99 in pre-market trading.
Via
Benzinga
Relmada Therapeutics Earnings Preview
May 04, 2022
Relmada Therapeutics (NASDAQ:RLMD) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy
April 06, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Here's Why Relmada Therapeutics Shares Are Rising
March 24, 2022
Relmada Therapeutics Inc (NASDAQ: RLMD) shares are trading higher by 7.2% at $25.01 after the company reported better-than-expected fourth-quarter EPS results. Relmada...
Via
Benzinga
Relmada Therapeutics's Earnings Outlook
March 22, 2022
Relmada Therapeutics (NASDAQ:RLMD) is set to give its latest quarterly earnings report on Wednesday, 2022-03-23. Here's what investors need to know before the announcement....
Via
Benzinga
Relmada Aces REL-1017 Vs Ketamine Study For Abuse Potential
February 23, 2022
Relmada Therapeutics Inc (NASDAQ: RLMD) has announced topline results of the human abuse potential (HAP) study with REL-1017 for major depressive disorder or MDD....
Via
Benzinga
Earnings Scheduled For March 23, 2022
March 23, 2022
Companies Reporting Before The Bell • AYRO (NASDAQ:AYRO) is expected to report earnings for its fourth quarter. • First Trust NASDAQ Clean Edge Smart Grid...
Via
Benzinga
Psychedelic Drugs Market Growing as Prevalence of Mental Health Issues are Increasing Globally
February 24, 2022
Palm Beach, FL –– February 24, 2022 – FinancialNewsMedia.com News Commentary – The prevalence of mental health disorders has risen exponentially but the development of novel medications has not kept...
Via
FinancialNewsMedia
Exposures
COVID-19
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.